The groundbreaking therapy of the medication represents a major development in the management of diabetes mellitus type 2. Unlike existing therapies, tirzepatide targets multiple pathways – glucagon-like peptide-1 https://tirzepatide-peptide443372.iyublog.com/40738019/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment